Web Analytics Made Easy - StatCounter

Xylocaine Aderline Inj Tenders

Get complete information related to latest Xylocaine Aderline Inj Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Xylocaine Aderline Inj Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Xylocaine Aderline Inj Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :44763791 Due date: 09 Apr, 202609 Apr, 2026 NA
Tender For supply of medicines mircera injection 50 mcg , darbepoetin alfa injection pfs 40 mcg , levocarnitine injection 1 g amp , cinacalcet tablet 30 mg , trastuzumab injection 440 mg vial , capecitabine tablet 500 mg , rosuvastatin 20mg+ ezetimibe 10mg , tablet , pancreatin cap 25000 units (creon 25000) , lenalidomide capsule 25 mg , denosumab injection 120 mg vial , levocarnitine injection 1 g amp , inj. teriperatide 750 mcg pen , inj. teriperatide 750mcg pen , gemcitabine injection 1400 mg vial , carboplatin injection 150 mg vial , romiplostim injection 250 mcg vial , pegfilgrastim injection 6 mg pfs , sodium bicarbonate tablet 500 mg , sodium bicarbonate tablet 1000 mg , inj.azacitidine 100 mg , capecitabine tablet 500 mg , leucovorin calcium injection 50 mg vial , oxaliplatin injection 100 mg , brivaracetam tablet 25 mg , t. syndopa 275 mg , pramipexole tablet 1 mg , tucatinib tablets 150 mg

CTN :44660859 Due date: 09 Apr, 202609 Apr, 2026 NA
Tender For supply of inj. oxaliplatin 100 mg [product should be available in the manufacturing firm's approved product list of railway board ]

Central Government / Public Sector

CTN :44585743 Due date: 02 Apr, 202602 Apr, 2026 NA
Tender For supply of mft_med_(ph no.:25025) oxaliplatin 100 mg inj

Central Government / Public Sector

CTN :44585749 Due date: 02 Apr, 202602 Apr, 2026 NA
Tender For supply of mft_med_(ph no.:25038) oxaliplatin 50 mg inj
 Loading, Please wait...

Connect us via What's Up